Adjust Glucocorticoid Treatment Based Solely on Clinical Response
STEP 1 — Gather Information
Collect clinical symptoms and signs of glucocorticoid over- or under-replacement: weight change, appetite, energy levels, blood pressure, peripheral edema, hyperpigmentation, and patient-reported well-being.
STEP 2 — Rule In / Rule Out
Is there clinical evidence of glucocorticoid excess or deficiency? If yes, proceed to classification; if no, maintain current dose and reassess in 4–6 weeks.
STEP 3 — Classify or Stratify
Classify as over-replacement (Cushingoid signs: weight gain, insomnia, peripheral edema, etc.), under-replacement (fatigue, weight loss, hypotension, hyperpigmentation, etc.), or adequate (stable weight, normal energy, no symptoms).
STEP 4 — Decide
If over-replacement, reduce glucocorticoid dose by 2.5–5 mg hydrocortisone equivalent; if under-replacement, increase dose by 2.5–5 mg; if adequate, continue current regimen.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on ACTH or cortisol levels to guide dosing; avoid over-reliance on hormonal monitoring. Symptoms can be nonspecific—consider concurrent illness, stress, or pregnancy. Avoid abrupt dose changes; taper adjustments. Monitor for signs of adrenal crisis during dose reduction.
Concrete Clinical Example
A 48-year-old man on hydrocortisone 15 mg daily reports progressive fatigue and 3 kg weight loss over 2 months, with postural hypotension; no Cushingoid signs. Clinical assessment suggests under-replacement; dose increased to 20 mg daily, with symptom reassessment scheduled in 4 weeks.
Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI: 10.1210/jc.2015-1710